Fulgent Genetics
FLGT· Services· Fiscal year ends in December
CEO pay in FY2025Stock +42.2% in FY2025
Ming Hsieh is the CEO of Fulgent Genetics and was paid $6.2M in FY2025 (Dec), up 1%.
Pay$100 in the stock at the end of FY20 → $50
Executives4
See all- 1Ming HsiehChief Executive OfficerFY2025
- 2Jian XiePresident and Chief Operating OfficerFY2025
- 3Paul KimChief Financial OfficerFY2025
- 4Hanlin GaoChief Scientific Officer and Laboratory DirectorFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allFulgent Genetics paid its 4 named executives $14.1M in total in FY2025 (Dec). CEO Ming Hsieh was paid $6.2M of that.
| Name | |||
|---|---|---|---|
| Ming HsiehChief Executive Officer | |||
| Jian XiePresident and Chief Operating Officer | |||
| Paul KimChief Financial Officer | |||
| Hanlin GaoChief Scientific Officer and Laboratory Director |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Fulgent Genetics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 31, 2026 | FY2025 |
| Annual report | 10-K | Feb 27, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 25, 2025 | FY2024 |
| Annual report | 10-K | Feb 28, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 27, 2024 | FY2023 |
| Annual report | 10-K | Feb 28, 2024 | FY2023 |
